Clinical Trials Logo

Neuromuscular Monitoring clinical trials

View clinical trials related to Neuromuscular Monitoring.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04947306 Completed - Clinical trials for Neuromuscular Blockade

A Comparison Between TOF Watch® SX and Tetragraph®

Start date: August 24, 2020
Phase:
Study type: Observational

This observational study was designed to assess the agreement between the recently marketed electromyographic neuromuscular blockade monitor Tetragraph® (Senzime, Uppsala, Sweden) and the TOF Watch® SX (Organon Teknika B.V., Boxtel, Holland), an accelerometric neuromuscular blockade monitor frequently used in clinical practice

NCT ID: NCT03804346 Completed - Clinical trials for Neuromuscular Blockade

Infantile - Postoperative Residual Curarization - Study

I-PORC
Start date: May 1, 2017
Phase:
Study type: Observational [Patient Registry]

The primary object of this study is, to investigate the current procedure of neuromuscular monitoring at a tertiary academic university medical center.

NCT ID: NCT02711917 Completed - Clinical trials for Neuromuscular Monitoring

Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane

Start date: July 2015
Phase: N/A
Study type: Interventional

Different concentration of sevoflurane was given to maintain anesthesia. The dose of propofol to maintain BIS between 40-60 and the consumption of rocuronium was recorded and evaluated.

NCT ID: NCT02630576 Completed - Electromyography Clinical Trials

Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy (Volunteers

NEAT-2
Start date: June 2015
Phase: N/A
Study type: Interventional

TetraGraph is a newly developed EMG-based (electromyograph), quantitative, battery-powered neuromuscular monitoring system intended for daily clinical use. The primary aim of this clinical investigation is to examine the applicability (ease of use, equipment need, etc.), repeatability (precision or internal consistency) and performance (signal quality, accuracy of outcome, voltage of stimulation output before and during a stimulus) and tolerability of the Tetragraph device in healthy volunteers.

NCT ID: NCT02350062 Completed - Clinical trials for Neuromuscular Monitoring

Comparison of Two Neuromuscular Monitors

NMT-STIMPOD
Start date: January 2014
Phase: N/A
Study type: Observational

Different neuromuscular monitors may be available in the same care structure. Two different monitors are available in the investigators' institution in the operative room and the recovery room. However, these two monitors have not been compared and may not be interchangeable. Starting the monitoring with one device and continuing with another device may be inaccurate and may lead to inadequate medical decisions. The investigators therefore conducted this observational study to compare the two devices available in our institution.

NCT ID: NCT02025309 Completed - Clinical trials for Neuromuscular Monitoring

Intraoperative Methylprednisolone and Sugammadex

Start date: December 2013
Phase: Phase 4
Study type: Interventional

Sugammadex, a modified γ-cyclodextrin is a selective relaxant-binding agent that reverses the effects of steroidal neuromuscular blocking agents, rocuronium and vecuronium. It shows its activity by encapsulating these. Likewise, some other steroid hormones and drugs like flucloxacillin, toremifene, fusidic acid can also be effected. Thus, assuming that methylprednisolone would also be encapsulated by sugammadex and decrease its efficiency, in this study we aimed to compare the recovery times from recuronium-induced muscle relaxation after reversal with sugammadex between patients who receive intraoperative methylprednisolone or not. After institutional review board (IRB) approval and informed consent, 100 patients will be enrolled in this prospective, single center, controlled study. Anaesthesia will be induced with propofol (3mg/kg) and rocuronium (0.6 mg/kg), followed by sevoflurane maintenance. Patients will be divided randomly into two groups methylprednisolone administered group and control group respectively). Neuromuscular blockade will be monitored using calibrated acceleromyography train-of-four (TOF WATCH SX Organon Ltd, Dublin, Ireland). Once rocuronium-induced neuromuscular blockade recovers spontaneously to TOF-count-two, all patients will receive 2.0 mg/kg of sugammadex. Neuromuscular monitoring will be continued until recovery of the TOF ratio to 0.9 at the ulnar nerve. The time to recovery of TOF to 0.9 will be compared in both groups. The statistical analyses will be performed using Student T Test and Mann-Whitney U test.